|
3M Drug Delivery Systems has a portfolio of patent protected toll-like receptor TLR7 and TLR8 agonists that have shown promise as vaccine adjuvants. 3M is actively seeking partners to license these assets on a non-exclusive basis.
3M also offers a Microstructured Transdermal System that provides an integrated adjuvant/delivery system for further product differentiation. 3M’s MTS technology penetrates the skin with minimal discomfort and provides intradermal delivery for drugs typically available only via injection.
www.3m.com/dds
^
|
|
Gold sponsor:
Silver sponsors:
  
Bronze sponsors:
  
Partner:
Documentation
Click here to review a comprehesive list of presentations given at Phacilitate's previous 19 Forums. All documentation is available to purchase.
|
|
